01 AI Is Becoming Integrated Directly into OCT Diagnostic Workflows The Optical Coherence Tomography Market is shifting from image acquisition alone toward AI-supported interpretation. Modern OCT platforms can use deep-learning algorithms to identify abnormal scans, improve segmentation, enhance OCT angiography images, and prioritize cases requiring closer clinical review. This helps ophthalmologists manage growing imaging volumes without manually examining every scan with the same intensity. AI integration is especially relevant for retinal diseases where repeated OCT examinations generate large datasets over time. The trend is expanding competition from hardware specifications toward software, clinical decision support, connectivity, and workflow efficiency. Manufacturers that combine high-resolution imaging with integrated AI can therefore deliver greater value to high-volume eye-care clinics. In August 2025, ZEISS received CE mark approval for CIRRUS PathFinder, which uses deep learning to automatically identify abnormal macular OCT B-scans and can assess hundreds of scans in real time.
01 Growing Retinal Disease Burden Is Increasing the Need for Early Imaging The large global burden of vision impairment is a major driver for OCT adoption because several important eye diseases require detailed examination and long-term monitoring of retinal structures. As populations age and chronic diseases become more common, ophthalmologists need efficient technologies for detecting structural changes and tracking disease progression. Greater emphasis on early diagnosis also supports repeated OCT use rather than one-time imaging. This creates continuing demand for scanners, software upgrades, image-management platforms, and clinical services across hospitals, specialty eye clinics, research centers, and community-based ophthalmology networks.
01 Unequal Access to Eye Care Limits OCT Deployment in Underserved Regions OCT systems require equipment investment, trained eye-care professionals, maintenance, interpretation capability, and reliable patient referral pathways. These requirements can restrict adoption in regions where basic eye-care services are already difficult to access. Advanced imaging provides limited benefit when healthcare systems lack enough ophthalmologists or infrastructure to evaluate patients and provide follow-up treatment. This creates a significant difference between technologically advanced eye clinics and underserved communities. Manufacturers must therefore address affordability, usability, training, and service availability if OCT is to expand beyond established specialist centers. Portable systems, teleophthalmology, and automated analysis can reduce some barriers, but broader healthcare access and workforce limitations remain important restraints on global market penetration.
01 OCT Angiography Creates Growth in Non-Invasive Vascular Imaging OCT angiography is creating an opportunity to expand OCT beyond structural imaging by visualizing retinal and choroidal blood vessels without conventional dye injection. This can strengthen assessment of vascular changes associated with retinal diseases and increase the clinical information generated from one imaging platform. Vendors can capture this opportunity by improving scan speed, image quality, segmentation, wide-field visualization, and software-assisted interpretation. OCT-A also creates opportunities for upgrades within the installed OCT base, allowing providers to add advanced imaging capabilities through compatible hardware and software. As clinicians gain more experience interpreting OCT-A data, the technology can become more deeply integrated into retinal diagnosis, monitoring, research, and personalized treatment planning.
01 Imaging Artifacts Can Reduce OCT Reliability and Interpretation Accuracy Maintaining reliable image quality remains a technical challenge as OCT systems become faster and more detailed. Patient movement, eye position, optical alignment, scanning geometry, and tissue characteristics can create artifacts that distort images or reduce signal quality. The challenge becomes greater as OCT expands into angiography, high-resolution research imaging, and home monitoring, where acquisition conditions may vary more widely than in controlled specialist clinics.
August 2025 Nidek expanded its ophthalmic diagnostic equipment portfolio with improvements in OCT imaging technologies designed for retinal analysis and anterior segment imaging. The company focused on enhancing image quality and clinical usability.
July 2025 Topcon Healthcare expanded its OCT and ophthalmic diagnostic portfolio through advancements in retinal imaging systems and integrated eye-care solutions. The company focused on improving early disease detection and supporting comprehensive eye examinations.
June 2025 Carl Zeiss Meditec expanded its ophthalmic imaging solutions with enhancements to OCT platforms, including improved visualization and diagnostic capabilities for retinal diseases and glaucoma management. The company continued focusing on integrating imaging technologies with clinical workflows.
May 2025 Heidelberg Engineering expanded its optical coherence tomography (OCT) imaging portfolio with continued advancements in spectral-domain and swept-source OCT technologies. The company focused on improving retinal imaging, diagnostic accuracy, and workflow efficiency in ophthalmology applications.